|
|
 |
|
Viewing report
|
|
|
|
Alizyme plc (AZM) - Financial and Strategic Analysis Review
GlobalData, Sep 2010, Pages: 26
Alizyme plc is a specialty biopharmaceutical development company that primarily focuses on the therapeutic areas of metabolic disorders, gastrointestinal disorders and cancer supportive care. It is engaged in developing products for the treatment and management of obesity and related conditions, such as type 2 diabetes, of gastrointestinal disorders involving inflammation, such as ulcerative colitis, and of the gastrointestinal side effects of cancer therapy, such as mucositis. Its products in development include Cetilistat for the treatment of obesity and associated conditions, COLAL-PRED for the treatment of ulcerative colitis and ATL-104 for mucositis.
This comprehensive SWOT profile of Alizyme plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note-: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key
competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered
in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and
efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Alizyme plc (AZM) - Strategic SWOT Analysis Review
Shire plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Salix Pharmaceuticals, Ltd.: Company Profile and SWOT Analysis
Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review
Atlas Energy, Inc. (ATLS) Oil and Gas Operations, key Strategies and SWOT Analysis
GW Pharmaceuticals plc (GWP) - Financial and Strategic SWOT Analysis Review
Hokkaido Gastrointestinal Cancer Study Group - Developmental Therapeutics Review - Q4 2010
Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review
Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review
Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review
|
|
|
|
